Titre : Galactose

Galactose : Questions médicales fréquentes

Termes MeSH sélectionnés :

Paraspinal Muscles
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Galactose : Questions médicales les plus fréquentes", "headline": "Galactose : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Galactose : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-04", "dateModified": "2025-03-01", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Galactose" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Hexose", "url": "https://questionsmedicales.fr/mesh/D006601", "about": { "@type": "MedicalCondition", "name": "Hexose", "code": { "@type": "MedicalCode", "code": "D006601", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D09.947.875.359" } } }, "about": { "@type": "MedicalCondition", "name": "Galactose", "alternateName": "Galactose", "code": { "@type": "MedicalCode", "code": "D005690", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Tilo Biedermann", "url": "https://questionsmedicales.fr/author/Tilo%20Biedermann", "affiliation": { "@type": "Organization", "name": "Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany." } }, { "@type": "Person", "name": "Eva Morava", "url": "https://questionsmedicales.fr/author/Eva%20Morava", "affiliation": { "@type": "Organization", "name": "Department of Paediatrics and Metabolic Center, University Hospitals Leuven, Leuven, Belgium. peter.witters@uzleuven.be." } }, { "@type": "Person", "name": "Scott P Commins", "url": "https://questionsmedicales.fr/author/Scott%20P%20Commins", "affiliation": { "@type": "Organization", "name": "Division of Rheumatology, Allergy, and Immunology, University of North Carolina, Chapel Hill, North Carolina." } }, { "@type": "Person", "name": "Marianne van Hage", "url": "https://questionsmedicales.fr/author/Marianne%20van%20Hage", "affiliation": { "@type": "Organization", "name": "Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet and University Hospital, Stockholm, Sweden." } }, { "@type": "Person", "name": "Michael Levin", "url": "https://questionsmedicales.fr/author/Michael%20Levin", "affiliation": { "@type": "Organization", "name": "Division of Paediatric Allergy, University of Cape Town, Cape Town, South Africa. Electronic address: Michael.levin@uct.ac.za." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Paraspinal Muscle Degeneration: A Potential Risk Factor for New Vertebral Compression Fractures After Percutaneous Kyphoplasty.", "datePublished": "2022-08-13", "url": "https://questionsmedicales.fr/article/35990803", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2147/CIA.S374857" } }, { "@type": "ScholarlyArticle", "name": "The association between paraspinal muscle parameters and vertebral pedicle microstructure in patients undergoing lumbar fusion surgery.", "datePublished": "2022-12-23", "url": "https://questionsmedicales.fr/article/36562815", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00264-022-05659-9" } }, { "@type": "ScholarlyArticle", "name": "Paraspinal Muscle Health is Related to Fibrogenic, Adipogenic, and Myogenic Gene Expression in Patients with Lumbar Spine Pathology.", "datePublished": "2022-06-24", "url": "https://questionsmedicales.fr/article/35739523", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12891-022-05572-7" } }, { "@type": "ScholarlyArticle", "name": "Understanding the Interplay Between Paraspinal Muscle Atrophy and Lumbar Endplate Degeneration: A 3-Year Longitudinal Study.", "datePublished": "2023-09-12", "url": "https://questionsmedicales.fr/article/37698271", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/BRS.0000000000004826" } }, { "@type": "ScholarlyArticle", "name": "Differences in lumbar paraspinal muscle morphology in patients with sagittal malalignment undergoing posterior lumbar fusion surgery.", "datePublished": "2022-08-29", "url": "https://questionsmedicales.fr/article/36038784", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00586-022-07351-3" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Glucides", "item": "https://questionsmedicales.fr/mesh/D002241" }, { "@type": "ListItem", "position": 3, "name": "Sucres", "item": "https://questionsmedicales.fr/mesh/D000073893" }, { "@type": "ListItem", "position": 4, "name": "Oses", "item": "https://questionsmedicales.fr/mesh/D009005" }, { "@type": "ListItem", "position": 5, "name": "Hexose", "item": "https://questionsmedicales.fr/mesh/D006601" }, { "@type": "ListItem", "position": 6, "name": "Galactose", "item": "https://questionsmedicales.fr/mesh/D005690" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Galactose - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Galactose", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-08", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Galactose", "description": "Comment diagnostiquer une intolérance à la galactose ?\nQuels tests sont utilisés pour détecter la galactosémie ?\nQuels symptômes indiquent un problème avec la galactose ?\nComment évaluer le métabolisme de la galactose ?\nQuel rôle joue l'enzyme galactose-1-phosphate uridyltransférase ?", "url": "https://questionsmedicales.fr/mesh/D005690?mesh_terms=Paraspinal+Muscles&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Galactose", "description": "Quels sont les symptômes d'une galactosémie ?\nComment se manifeste l'intolérance au galactose ?\nQuels signes indiquent une surcharge de galactose ?\nLa galactose peut-elle causer des problèmes oculaires ?\nQuels symptômes neurologiques sont associés à la galactosémie ?", "url": "https://questionsmedicales.fr/mesh/D005690?mesh_terms=Paraspinal+Muscles&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Galactose", "description": "Comment prévenir la galactosémie chez les nouveau-nés ?\nLes femmes enceintes doivent-elles se soucier de la galactose ?\nQuels aliments éviter pour prévenir l'intolérance au galactose ?\nLe dépistage génétique est-il utile pour la galactosémie ?\nComment sensibiliser à la galactosémie ?", "url": "https://questionsmedicales.fr/mesh/D005690?mesh_terms=Paraspinal+Muscles&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Galactose", "description": "Quel est le traitement principal de la galactosémie ?\nPeut-on utiliser des suppléments pour la galactosémie ?\nComment gérer l'intolérance au galactose ?\nY a-t-il des médicaments pour traiter la galactosémie ?\nComment surveiller l'évolution d'une galactosémie ?", "url": "https://questionsmedicales.fr/mesh/D005690?mesh_terms=Paraspinal+Muscles&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Galactose", "description": "Quelles complications peuvent survenir avec la galactosémie ?\nLa galactosémie peut-elle affecter le développement physique ?\nQuels risques neurologiques sont associés à la galactosémie ?\nComment la galactosémie affecte-t-elle le foie ?\nY a-t-il des complications à long terme de la galactosémie ?", "url": "https://questionsmedicales.fr/mesh/D005690?mesh_terms=Paraspinal+Muscles&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Galactose", "description": "Quels sont les facteurs de risque de la galactosémie ?\nLa consanguinité augmente-t-elle le risque de galactosémie ?\nLes femmes porteuses de gènes de galactosémie doivent-elles s'inquiéter ?\nLes populations spécifiques sont-elles plus à risque ?\nComment les tests génétiques aident-ils à évaluer le risque ?", "url": "https://questionsmedicales.fr/mesh/D005690?mesh_terms=Paraspinal+Muscles&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une intolérance à la galactose ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un test de tolérance au galactose et des analyses sanguines peuvent confirmer l'intolérance." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour détecter la galactosémie ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests génétiques et des dosages de galactose dans le sang sont utilisés." } }, { "@type": "Question", "name": "Quels symptômes indiquent un problème avec la galactose ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la diarrhée, les vomissements et la jaunisse peuvent indiquer un problème." } }, { "@type": "Question", "name": "Comment évaluer le métabolisme de la galactose ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de métabolisme et des analyses enzymatiques peuvent évaluer la dégradation de la galactose." } }, { "@type": "Question", "name": "Quel rôle joue l'enzyme galactose-1-phosphate uridyltransférase ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Cette enzyme est cruciale pour le métabolisme de la galactose et son absence cause des troubles." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une galactosémie ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent vomissements, diarrhée, jaunisse et retard de croissance." } }, { "@type": "Question", "name": "Comment se manifeste l'intolérance au galactose ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elle se manifeste par des douleurs abdominales, des ballonnements et des diarrhées après ingestion." } }, { "@type": "Question", "name": "Quels signes indiquent une surcharge de galactose ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme la fatigue, des troubles neurologiques et des problèmes hépatiques peuvent apparaître." } }, { "@type": "Question", "name": "La galactose peut-elle causer des problèmes oculaires ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une accumulation de galactose peut entraîner des cataractes et d'autres problèmes oculaires." } }, { "@type": "Question", "name": "Quels symptômes neurologiques sont associés à la galactosémie ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles du développement, des convulsions et des retards mentaux peuvent survenir." } }, { "@type": "Question", "name": "Comment prévenir la galactosémie chez les nouveau-nés ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Le dépistage néonatal permet de détecter la galactosémie et d'initier un traitement précoce." } }, { "@type": "Question", "name": "Les femmes enceintes doivent-elles se soucier de la galactose ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles doivent surveiller leur consommation de galactose, surtout si des antécédents familiaux existent." } }, { "@type": "Question", "name": "Quels aliments éviter pour prévenir l'intolérance au galactose ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Évitez les produits laitiers, les légumineuses et certains fruits comme les cerises." } }, { "@type": "Question", "name": "Le dépistage génétique est-il utile pour la galactosémie ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut identifier les porteurs et les personnes à risque de développer la maladie." } }, { "@type": "Question", "name": "Comment sensibiliser à la galactosémie ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Des campagnes d'information et des ressources éducatives peuvent aider à sensibiliser le public." } }, { "@type": "Question", "name": "Quel est le traitement principal de la galactosémie ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement consiste à suivre un régime strict sans galactose, excluant les produits laitiers." } }, { "@type": "Question", "name": "Peut-on utiliser des suppléments pour la galactosémie ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des suppléments de calcium et de vitamine D peuvent être nécessaires en raison d'un régime restrictif." } }, { "@type": "Question", "name": "Comment gérer l'intolérance au galactose ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les aliments contenant du galactose et consulter un diététicien pour un suivi." } }, { "@type": "Question", "name": "Y a-t-il des médicaments pour traiter la galactosémie ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de médicaments spécifiques, le régime est le traitement principal." } }, { "@type": "Question", "name": "Comment surveiller l'évolution d'une galactosémie ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des contrôles réguliers des niveaux de galactose et des évaluations cliniques sont nécessaires." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec la galactosémie ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des problèmes hépatiques, des cataractes et des troubles neurologiques." } }, { "@type": "Question", "name": "La galactosémie peut-elle affecter le développement physique ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut entraîner un retard de croissance et des problèmes de développement physique." } }, { "@type": "Question", "name": "Quels risques neurologiques sont associés à la galactosémie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des convulsions, des retards mentaux et des troubles du comportement peuvent survenir." } }, { "@type": "Question", "name": "Comment la galactosémie affecte-t-elle le foie ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut provoquer une hépatomégalie et des lésions hépatiques dues à l'accumulation de galactose." } }, { "@type": "Question", "name": "Y a-t-il des complications à long terme de la galactosémie ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des complications à long terme incluent des troubles cognitifs et des problèmes de vision." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque de la galactosémie ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents familiaux de galactosémie et certaines mutations génétiques augmentent le risque." } }, { "@type": "Question", "name": "La consanguinité augmente-t-elle le risque de galactosémie ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la consanguinité peut augmenter le risque de transmission de la galactosémie." } }, { "@type": "Question", "name": "Les femmes porteuses de gènes de galactosémie doivent-elles s'inquiéter ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent transmettre le gène à leurs enfants, augmentant le risque de la maladie." } }, { "@type": "Question", "name": "Les populations spécifiques sont-elles plus à risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Certaines populations, comme les Ashkénazes, ont un risque plus élevé de galactosémie." } }, { "@type": "Question", "name": "Comment les tests génétiques aident-ils à évaluer le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Les tests génétiques peuvent identifier les porteurs et évaluer le risque de transmission." } } ] } ] }

Sources (10000 au total)

Paraspinal Muscle Degeneration: A Potential Risk Factor for New Vertebral Compression Fractures After Percutaneous Kyphoplasty.

The paraspinal muscle is essential for maintaining normal spine function and structure, which degeneration is closely related to various spinal diseases. The main objective of this study was to identi... A total of 202 patients with single-level osteoporotic vertebral compression fractures (OVCF) who underwent percutaneous kyphoplasty treatment between January 2016 and March 2019 were included in this... NVCF occurred in 54 of 202 patients (26.7%). The erector spinae FSF (OR = 1.064; P = 0.001), psoas major FSF (OR = 1.326; P < 0.001), and the difference index of the muscle CSA between multifidus and ... Paraspinal muscle degeneration is a potential risk factor for NVCF occurrence. A nomogram was designed to precisely predict the risk of NVCF. This predictive nomogram may help clinicians to make bette...

The association between paraspinal muscle parameters and vertebral pedicle microstructure in patients undergoing lumbar fusion surgery.

Lumbar fusion surgery has become a standard procedure in spine surgery and commonly includes the posterior placement of pedicle screws. Bone quality is a crucial factor that affects pedicle screw purc... Prospectively, collected data of patients undergoing posterior lumbar fusion for degenerative spinal conditions was analyzed. Pre-operative lumbar magnetic resonance imaging (MRI) scans were evaluated... A total of 26 patients with a mean age of 59.1 years and a mean BMI of 29.8 kg/m... This study highlights the close interactions between the bone microstructure of the lumbar pedicle and the paraspinal muscle morphology. These findings give us further insights into the interaction be...

Paraspinal Muscle Health is Related to Fibrogenic, Adipogenic, and Myogenic Gene Expression in Patients with Lumbar Spine Pathology.

Lumbar spine pathology is a common feature of lower back and/or lower extremity pain and is associated with observable degenerative changes in the lumbar paraspinal muscles that are associated with po... Multifidus muscle biopsies were obtained from patients (n = 59) undergoing surgery for lumbar spine pathology to analyze 42 genes from relevant adipogenic/metabolic, atrophic, fibrogenic, inflammatory... Relationships between gene expression and imaging revealed significant associations between decreased expression of adipogenic/metabolic gene (PPARD), increased expression of fibrogenic gene (COL3A1),... Fibrogenic and adipogenic/metabolic genes were related to pre-operative muscle quality, and myogenic genes were related to pre-operative muscle size. These findings provide insight into molecular path...

Understanding the Interplay Between Paraspinal Muscle Atrophy and Lumbar Endplate Degeneration: A 3-Year Longitudinal Study.

Retrospective analysis of longitudinal data.... To assess the association between the paraspinal musculature (PM) and lumbar endplate degeneration.... The PM is essential for spinal stability, while the vertebral endplate is pivotal for nutrient transport and force distribution. The clinical importance of both has been highlighted in recent literatu... We identified patients with lumbar MRI scans due to low back pain, with a 3-year interval between MRI scans. Endplate damage was assessed by the total endplate score (TEPS) at each lumbar level. The P... In all, 329 patients were included, with a median follow-up time of 3.4 years. Participants had a median age of 59 and a BMI of 25.8 kg/m 2 . In the univariate analysis, FI of the posterior PM was sig... This is the first longitudinal study assessing the relationship between PM and endplate degeneration, demonstrating the association between PM atrophy and the progression of endplate degeneration. Thi...

Differences in lumbar paraspinal muscle morphology in patients with sagittal malalignment undergoing posterior lumbar fusion surgery.

To investigate whether (1) there is a difference between patients with normal or sagittal spinal and spinopelvic malalignment in terms of their paraspinal muscle composition and (2) if sagittal malali... A retrospective review of patients undergoing posterior lumbar fusion surgery was conducted. A MRI-based muscle measurement technique was used to assess the cross-sectional area, the functional cross-... One hundred and fifty patients were analysed. The PI-LL and SVA malalignment groups were found to have a significantly higher FI... Significant differences in the muscle composition between normal and malalignment groups with respect to FI...

The fatty infiltration into cervical paraspinal muscle as a predictor of postoperative outcomes: A controlled study based on hybrid surgery.

The cervical paraspinal muscle (CPM) has an essential role in positioning, stabilizing and directing the cervical spine. However, information is lacking regarding the influence of CPM on outcomes foll... A retrospective analysis was performed on 110 consecutive patients undergoing continuous 2-level HS. According to Goutallier classification of multifidus FI, the patients were divided into normal, mod... Visible FI was identified in 69.1% of patients (76/110), with a propensity in elderly patients (p = 0.053). No statistically significant differences were presented among the three groups regarding pre... CPM degeneration is common and age-related in patients with cervical disc degenerative disease. More importantly, there was a significant positive correlation between severe FI of CPM and postoperativ...

Osteosarcopenia in the Spine Beyond Bone Mineral Density: Association Between Paraspinal Muscle Impairment and Advanced Glycation Endproducts.

Prospective cross-sectional study.... To determine if an accumulation of advanced glycation endproducts (AGEs) is associated with impaired paraspinal muscle composition.... Impaired bone integrity and muscle function are described as osteosarcopenia. Osteosarcopenia is associated with falls, fragility fractures, and reduced quality of life. Bone integrity is influenced b... Intraoperative bone biopsies from the posterior superior iliac spine were obtained and evaluated with multiphoton microscopy for fluorescent AGE cross-link density (fAGEs). Preoperative magnetic reson... One hundred seven prospectively enrolled patients (50.5% female, age 60.7 y, BMI 28.9 kg/m 2 ) were analyzed. In all, 41.1% and 15.0% of the patients demonstrated osteopenia and osteoporosis, respecti... This is the first investigation demonstrating that an accumulation of nonenzymatic collagen cross-linking product fAGEs in cortical bone is associated with increased intramuscular fat in the lumbar pa...

Kinematics and paraspinal muscle activation patterns during walking differ between patients with lumbar spinal stenosis and controls.

The narrowing of the spinal canal due to degenerative processes may lead to symptomatic lumbar spinal stenosis (sLSS) and impairments in the patients' gait. Changes in lower extremity joint kinematics... Do muscle activation patterns together with sagittal joint kinematics differ between patients with sLSS and healthy controls and do these differences-quantified using gait scores-correlate with clinic... In 20 patients with sLSS scheduled for surgery and 19 healthy participants, gait was assessed using seven inertial sensors and muscle activation of gluteus medius, erector spinae and multifidus using ... Patients had larger mGPS (+1.9°) and EMG-Profile Scores (+50%) and walked on average slower (-0.26 m/s) than controls. EMG patterns revealed higher activation of multifidus, erector spinae and gluteus... Observed differences in gait and muscle activation patterns and in the summary scores of gait and EMG deviations between patients with sLSS and healthy controls may represent additional functional out...

Age- and sex-dependent differences in the morphology and composition of paraspinal muscles between subjects with and without lumbar degenerative diseases.

The quality of the paraspinal muscles has been recommended as a surrogate marker for the evaluation of the severity of the lumbar degenerative diseases (LDD). The purpose of this study is to determine... We analyzed data from 370 patients and 327 asymptomatic volunteers aged between 18-85 years. The measurement of the cross-sectional area (CSA) of the erector spinae, multifidus, and psoas at the L4/5-... FI % of the lumbar paraspinal muscles were significantly and positively correlated with the severity of LDD instead of the CSA. Males had greater CSA than females, and females showed higher FI % than ... Age- and sex-dependent differences were found in the morphology and composition of the paraspinal muscles between subjects with and without LDD. Further long-term follow up investigations and basic st...

Risk factors for residual back pain following percutaneous vertebral augmentation: the importance of paraspinal muscle fatty degeneration.

Residual back pain (RBP) after percutaneous vertebral augmentation (PVA) still exists considerable, and it even affects daily life due to moderate or severe back pain. A variety of risk factors have b... We retrospectively reviewed the medical records of patients with single-segment OVCF who underwent PVA from January 2016 to January 2022. Patients were divided into RBP group (86 patients) and control... The results of multivariate logistical regression analysis revealed that posterior fascia injury (odds ratio (OR) = 5.23; 95% confidence interval (CI) 3.12-5.50; P < 0.001), as regards paraspinal musc... Posterior fascia injury, paraspinal muscle fatty degeneration, and facet joint violation were identified as independent risk factors for RBP, with paraspinal muscle fatty degeneration playing an impor...